about
Alendronate inhibits PTH (1-34)-induced bone morphogenetic protein expression in MC3T3-E1 preosteoblastic cellsA probable case of oral bisphosphonate-associated osteonecrosis of the jaw and recovery with parathyroid hormone treatment.Effect of a sequential treatment combining abaloparatide and alendronate for the management of postmenopausal osteoporosis.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Combination/sequential therapy in osteoporosis.
@ast
Combination/sequential therapy in osteoporosis.
@en
type
label
Combination/sequential therapy in osteoporosis.
@ast
Combination/sequential therapy in osteoporosis.
@en
prefLabel
Combination/sequential therapy in osteoporosis.
@ast
Combination/sequential therapy in osteoporosis.
@en
P2860
P1476
Combination/sequential therapy in osteoporosis.
@en
P2093
Marie-Paul Lecart
Olivier Bruyere
P2860
P2888
P304
P356
10.1007/S11914-996-0011-8
P577
2004-12-01T00:00:00Z